Cargando…

Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma

SIMPLE SUMMARY: Oral squamous cell carcinoma (OSCC) is the most widespread malignancy of the head and neck and is characterized by a high potential for local invasion and lymph node metastasis. Serum response factor (SRF) regulates pro-carcinogenic genes in various cancers, but its role in OSCC rema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Mingyan, Zhu, Feixiang, Yin, Qi, Yin, Hao, Fang, Shaobin, Luo, Gongwei, Huang, Jie, Huang, Wenxia, Liu, Fan, Zhong, Ming, Deng, Xiaoling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954402/ https://www.ncbi.nlm.nih.gov/pubmed/36831659 http://dx.doi.org/10.3390/cancers15041319

Ejemplares similares

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy
por: Shi, Jing, et al.
Publicado: (2019)

Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
por: Du, Lisha, et al.
Publicado: (2020)

Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
por: Du, Lisha, et al.
Publicado: (2021)

Synergistic effect of endurance training and nettle leaf extract on the IDO1-KYN-AHR pathway homeostasis and inhibiting of liver toxicity in rats with STZ-induced diabetes
por: Haghshenas, Rouhollah, et al.
Publicado: (2023)

TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
por: Li, Lei, et al.
Publicado: (2021)

Comparison of moderate-intensity continuous training and high-intensity interval training effects on the Ido1-KYN-Ahr axis in the heart tissue of rats with occlusion of the left anterior descending artery
por: Nori, Pouria, et al.
Publicado: (2023)

The Gut Microbiota Activates AhR Through the Tryptophan Metabolite Kyn to Mediate Renal Cell Carcinoma Metastasis
por: Dai, Guoyu, et al.
Publicado: (2021)

Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma
por: Meireson, Annabel, et al.
Publicado: (2021)

Immunological Relevance of the Coevolution of IDO1 and AHR
por: Jaronen, Merja, et al.
Publicado: (2014)

Cancer Associated Fibroblasts Promote Renal Cancer Progression Through a TDO/Kyn/AhR Dependent Signaling Pathway
por: Chen, Li-bo, et al.
Publicado: (2021)

AhR-Mediated, Non-Genomic Modulation of IDO1 Function
por: Pallotta, Maria Teresa, et al.
Publicado: (2014)

The Coevolution of IDO1 and AhR in the Emergence of Regulatory T-Cells in Mammals
por: Grohmann, Ursula, et al.
Publicado: (2015)

MiR-199a-5p-Regulated SMARCA4 Promotes Oral Squamous Cell Carcinoma Tumorigenesis
por: Xu, Mingyan, et al.
Publicado: (2023)

Tryptophan Feeding of the IDO1-AhR Axis in Host–Microbial Symbiosis
por: Zelante, Teresa, et al.
Publicado: (2014)

Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer
por: Kado, Sarah Y., et al.
Publicado: (2023)

Kyn Taniya’s Radio (1924): Journeys of a Cosmic Cosmopolitan
por: Jalife Jacobo, Anuar
Publicado: (2023)

AhR and IDO1 in pathogenesis of Covid-19 and the “Systemic AhR Activation Syndrome:” a translational review and therapeutic perspectives
por: Turski, Waldemar A., et al.
Publicado: (2020)

Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
por: Liu, Yuying, et al.
Publicado: (2017)

The IDO–AhR Axis Controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection
por: de Araújo, Eliseu Frank, et al.
Publicado: (2017)

IDO in Colorectal Tumorigenesis: Involvement of Immune Tolerance and Significance in Prevention and Therapy
por: Tang, Shunan, et al.
Publicado: (2021)

Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
por: Litzenburger, Ulrike M., et al.
Publicado: (2014)

IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
por: Chen, Xiangli, et al.
Publicado: (2020)

Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance
por: Zhang, Xin, et al.
Publicado: (2021)

Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1
por: Brincks, Erik L., et al.
Publicado: (2020)

Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway
por: Duan, Ruo-Nan, et al.
Publicado: (2021)

Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder
por: Lin, Ping, et al.
Publicado: (2023)

FOXO1 inhibits FSL-1 regulation of integrin β6 by blocking STAT3 binding to the integrin β6 gene promoter
por: Xu, Mingyan, et al.
Publicado: (2022)

Correction: Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway
por: Duan, Ruo-Nan, et al.
Publicado: (2023)

Targeting the IDO-BCL2A1-Cytochrome c Pathway Promotes Apoptosis in Oral Squamous Cell Carcinoma
por: Zheng, Qiaoping, et al.
Publicado: (2021)

Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma
por: Gan, Ning, et al.
Publicado: (2017)

IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma
por: Struckmeier, Ann-Kristin, et al.
Publicado: (2022)

The Oral Mouse Microbiome Promotes Tumorigenesis in Oral Squamous Cell Carcinoma
por: Stashenko, Philip, et al.
Publicado: (2019)

Dehydrocorydaline inhibits the tumorigenesis of breast cancer MDA-MB-231 cells
por: Huang, Ying, et al.
Publicado: (2020)

Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder
por: Umehara, Hidehiro, et al.
Publicado: (2017)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

AhR transcriptional activity in serum of Inuits across Greenlandic districts
por: Long, Manhai, et al.
Publicado: (2007)

Relationship of SOCS3 and TGF-β with IDO expression in early pregnancy chorionic villi and decidua
por: Liu, Wei, et al.
Publicado: (2017)

Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
por: Safe, Stephen, et al.
Publicado: (2020)

The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
por: Gargaro, Marco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0ihi97u15sb4qbgi2l792hjo02